Acute lymphoblastic leukemia, childhood

Active Research Protocols

  1. 08-C-0123 РA Phase 1, Multi-Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (ALL) or Non-Hodgkin̥s Lymphoma (NHL)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014